New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Clinical trial NCT01360021 · COMPLETED
Trial details
- NCT number
- NCT01360021
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-08-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.